Folgen
-
In this episode, we dive into the fascinating journey of Lars Dreesmann, President of Boehringer Ingelheim Fremont. Join us as Lars shares his story of growth, from his early interest in biology to his transition into the pharmaceutical industry, and the challenges he faced relocating to California during the pandemic. Learn about his role at Boehringer, the cultural differences between Germany and the U.S., and the evolution of work practices post-pandemic. Don't miss this engaging conversation about personal and professional growth in the pharma industry!
-
Adina Pelusio, SVP of Clinical Operations at Kalivir Immunotherapeutics. Adina's journey from a chance job offer to a leading role in biotech is nothing short of motivational. Learn how she navigated her career, the value of saying 'yes' to opportunities, and the importance of mentorship.
-
Fehlende Folgen?
-
This week, we talk to Robert Goldman and Justin Rudolph from Alcoa Consulting about their innovative two-for-one consulting model. If you're a biotech startup or a large CRO, this episode is packed with insights on how to leverage experienced consultants without breaking the bank. Their 360-degree experience in biotech and CRO industries is a game-changer. Listen now!
-
Networking is key in today's job market! Chiara Invernizzi shares invaluable insights on leveraging LinkedIn and building connections to advance your career. From moving countries to navigating different corporate cultures today we hear Chiara’s challenges and triumphs.
-
Dr. Sanjeev Chopra, a professor of medicine at Harvard Medical School and Edward Alano, founder of Arrow DX share groundbreaking insights on the intersection of AI, machine learning, and healthcare in our latest podcast episode. Dr. Chopra and Edward discuss their journey and vision for transforming the healthcare industry using cutting-edge technology.
-
Dive into the inspiring career journey of Chris Howard, a trailblazer in clinical operations and project management in the life sciences sector. From her pioneering contributions to Johnson and Johnson’s wellness programs to shaping the standards of project management in clinical trials, discover the challenges she faced and the heights she reached. ✨ #WomenInSTEM #Leadership
-
This week James speaks to Dr Daniel Fox on
Transforming Autism research - Building a community for Integration and trials.
Proving the doubters wrong – The Successful SOS Conference
Revolutionising the conference culture and entrepreneurship
-
This week James speaks to Mike Tush, CEO of Treadwell Therapeutics. Mike shares his fascinating career trajectory, from his early fascination with STEM pursuits to his unexpected journey through pharmaceuticals, biotech, and clinical research.
The discussion delves into his experiences on Wall Street as an equity analyst and hedge fund manager, his transition back into the biotech space, and his role as CEO of Treadwell Therapeutics.
Throughout the conversation, Mike emphasizes the importance of making a difference in patient's lives and the critical role of effective leadership and teamwork in the pharmaceutical industry.
-
This week James speaks to Lisa Sonneborn about starting her own research site with the money she had saved for her wedding. Subsequently growing and selling that site to joining Ichor and setting up Ichor Clinical. Lisa shares her challenges and wins in building ICorps Clinical as well as sharing her golden rules for life and business.
Tune into Lisa’s story today.
-
In this episode of the Huxley Morton Podcast, James is joined by Carlos Martin, the Chief Commercial Officer and Head of International at Rocket Pharma.
Carlos shares his journey from working in various roles at Novartis Oncology to embracing the entrepreneurial spirit at Rocket Pharma.
As CCO, he discusses the focus on developing gene therapies for treating rare pediatric conditions. Carlos emphasizes the importance of transitioning the company from a clinical-stage to a commercial-stage biotech firm while aligning with their mission to eradicate rare diseases using gene therapies.
He provides an insight into the challenges and strategies of creating, delivering, and commercializing complex therapeutics.
-
Delve into the inspiring journey of Matt Walsh, the CEO of Trialbee.
Matt shares his personal story of how his daughter's battle with cancer led him to Trialbee's mission of raising awareness about clinical trials.
He talks about the importance of culture in a company's success and how Trialbee's focus on culture has helped them become a magnet for talent.
Matt also discusses the company's strategy, his leadership style, and the challenges and achievements of his tenure at Trialbee.
#patientrecruitment #clinicaltrials #clinicalresearch #oncology
-
Meet Victor Dillard, the glue of Resolution Therapeutics, as he shares his exciting journey from founding a biotech startup to innovating new cell therapy solutions. Tune in to our latest episode to hear all about Victor's vision for revolutionizing liver disease treatment options. #podcast #Biotech #CellTherapy
-
Welcome to the latest episode of the Huxley Morton podcast. In this episode, Joy Clark, Chief People Officer at Worldwide Clinical Trials, shares her journey to her current role, her approach to nurturing company culture, and how she helps to manage a diverse and dedicated team.
Learn about her experiences starting in her family business and gradually transitioning into her current role, where she oversees a team supporting Worldwide's operations in over 60 countries.
Gain insights into how she fosters an inclusive and collaborative culture, strategies for hiring talent during uncertain times, and her thoughts on diversity, fairness, and career growth in the workplace.
Join us for this engaging conversation that highlights the intricacies of people, culture, and leadership in the pharmaceutical industry.
-
In an engaging conversation, James and Charles Gelman of HIDO Health discuss HIDO, an innovative healthcare technology. HIDO, short for Health Information Data Outcomes, prioritizes patient-centered care by providing hospital-quality support at home.
This device ensures medication adherence, fosters interaction to combat isolation, and enhances mental health. With a focus on clinical research partnerships, HIDO aims to deliver precise, real-time data for improved healthcare results.
This approach not only meets patient needs but also has the potential to revolutionize clinical trials, providing accurate insights and a reliable platform for better drug development.
The conversation underscores HIDO's mission to optimize medication outcomes, promising a patient-centric future in healthcare.
-
In this week's episode, Matt and Stephen from BlueGreen Clinical, discuss their journey from a global pharmaceutical company, GW Jazz, to launching their consultancy.
They share insights on the transition to entrepreneurship, networking, establishing a client base, and the importance of trusted relationships in the healthcare industry.
The conversation touches on leadership lessons, embracing failures, the power of curiosity, and maintaining a balance in work and personal life.
-
In this episode, we dive deep into the dynamic world of biotechnology with Industry leader Neil Sankar.
With a successful career spanning both big pharma and small biotech companies, Neil shares his insights into the industry, the challenges it presents, and how he has managed to stay motivated and engaged.
From drug development to therapeutic strategies, Neil's wealth of knowledge is sure to provide valuable insights for professionals in the field and those looking to understand the intricacies of the biotech world.
Join us for a fascinating discussion on biotech, strategy, and the critical role of time management in Neil's remarkable career.
-
This week we speak to Robert Buckley, the Chief People Architect at Enveda Biosciences, who shares invaluable advice for jobseekers.
Tune in as Robert discusses how to measure a company's hiring process, the importance of transparency in candidate experiences, and the key qualities he looks for when building high-performing teams.
Discover tips to stand out as a candidate and gain a deeper understanding of how to thrive in a company culture that values purpose, trust, and constant learning.
Learn more about Enveda Biosciences https://www.envedabio.com/
Struggling with your Job Search take a look at our Career Growth Accelerator program.
https://careergrowthaccelerator.thinkific.com/courses/your-first-course
-
From a small startup to a global organization, dedicated to treating rare inflammatory autoimmune diseases.
This week we speak to Dr. Jeff Sherman, the Chief Medical Officer at Horizon Therapeutics, a leading biopharmaceutical company that has recently been acquired by Amgen for approximately $27.8 billion.
Dr. Sherman highlights the significance of addressing unmet medical needs and discusses the company's commitment to patients, communities, and healthcare providers. He also reflects on the impact of COVID-19 on their operations and the importance of a sense of urgency in the field of rare diseases.
In the quickfire questions section, Dr. Sherman offers advice to his younger self, outlines the qualities he values most in team members, and emphasizes the value of treating others as you would want to be treated. He also shares his perspective on work-life balance and the joys of being a grandparent.
For more information about Horizon Therapeutics and their work in rare diseases, visit their website at horizontherapeutics.com.
-
In this episode, Bryan Spielman, Chief Growth Officer at Advarra, takes us on his journey from the world of investment banking to the mission-driven clinical trial industry.
Bryan shares insights into the challenges and rewards of transforming Advara, emphasizing the importance of building long-term relationships, embracing innovation, and balancing purpose with profit.
Join us as we explore Bryan's strategies for sustainable growth and his commitment to making a lasting impact on the clinical research ecosystem.
-
Matt Veatch a life sciences consultant, discusses the benefits of freelance consulting in the Clinical Research industry, including higher-level engagements with decision-makers and the opportunity to pursue other passions.
He also talks about the challenges of brokering access to highly specialized datasets for research projects.
The podcast explores the evolving landscape of consulting in the life sciences industry and the potential for temporary-to-permanent transitions.
- Mehr anzeigen
